Association of the Cylin D1 G870A Polymorphism with Laryngeal Cancer: Are they Really Related? |
Verim, Aysegul
(Department of Otorhinolaryngology/Head and Neck Surgery, Haydarpasa Numune Education and Research Hospital)
Ozkan, Nazli (Department of Molecular Medicine, Istanbul University Experimental Research Institute) Turan, Saime (Department of Molecular Medicine, Istanbul University Experimental Research Institute) Korkmaz, Gurbet (Department of Molecular Medicine, Istanbul University Experimental Research Institute) Cacina, Canan (Department of Molecular Medicine, Istanbul University Experimental Research Institute) Yaylim, Ilhan (Department of Molecular Medicine, Istanbul University Experimental Research Institute) Isbir, Turgay (Multidiciplinary Molecular Medicine Department, Institute of Health Sciences, Yeditepe University) |
1 | Shu XO, Moore DB, Cai Q, et al (2005). Association of cyclin D1 genotype with breast cancer risk and survival. Cancer Epidemiol Biomarkers Prev, 14, 91-7. |
2 | Simpson DJ, Fryer AA, Grossman AB, et al (2001). Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas. Carcinogenesis, 22, 1801-7. DOI ScienceOn |
3 | Solomon DA, Wang Y, Fox SR, et al (2003). Cyclin D1 splice variants.Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem, 278, 30339-47. DOI ScienceOn |
4 | Tuncer M, Ozgul N, Olcayto EO, Gultekin M, Erdin B (2009). Turkish Republic, Ministry of Health, National Cancer Control Department, National Cancer Programme, 2009-15. |
5 | Wang R, Zhang JH, Li Y, et al (2003). The association of cyclin D1 (A870G) polymorphism with susceptibility to esophageal and cardiac cancer in north Chinese population. Zhonghua Yi Xue Za Zhi, 83, 1089-92. |
6 | Izzo JG, Papadimitrakopoulou VA, Liu DD, et al (2003). Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer. J Natl Cancer Inst, 95, 198-205. DOI ScienceOn |
7 | Jain M, Kumar S, Upadhyay R, et al (2007). Influence of apoptosis (BCL2,FAS), cell cycle (CCND1) and growth factor (EGF,EGFR) genetic polymorphisms on survival outcome: an exploratory study in squamous cell esophageal cancer. Cancer Biol Ther, 6, 1553-8. DOI |
8 | Jares P, Fernandez PL, Campo E, et al (1994). PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res, 54, 4813-7. |
9 | Knudsen KE, Diehl JA, Haiman CA, Knudsen ES (2006). Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene, 25, 1620-8. DOI ScienceOn |
10 | Koufman JA, Burke AJ (1997). The etiology and pathogenesis of laryngeal carcinoma. Otolaryngol Clin North Am, 30, 1-19. |
11 | Krippl P, Langsenlehner U, Renner W, et al (2003). The 870G4A polymorphism of the cyclin D1 gene is not associated with breast cancer. Breast Cancer Res Treat, 54, 165-8. |
12 | Landis SH, Murray T, Bolden S, Wingo PA( 1998). Cancer statistics, CA Cancer J Clin, 48, 6-29. DOI ScienceOn |
13 | Matthias C, Branigan K, Jahnke V, et al (1998). Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res, 4, 2411-8. |
14 | Matthias C, Jahnke V, Jones PW, et al (1999). Cyclin D1, glutathione S-transferase, and cytochrome P450 genotypes and outcome in patients with upper aerodigestive tract cancers: assessment of the importance of individual genes using multivariate analysis. Cancer Epidemiol Biomarkers Prev, 8, 815-23. |
15 | Michalides R, van Veelen N, Hart A, et al (1995).Overexpression of cyclin D1 correlates with recurrence in a group of fortyseven operable squamous cell carcinomas of the head and neck. Cancer Res, 55, 975-8. |
16 | Miller SA, Dykes DD, Polesky HF(1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 16, 1215. DOI ScienceOn |
17 | Monteiro E, Varzim G, Pires AM, Teixeira M, Lopes C(2004). Cyclin D1 A870G polymorphism and amplification in laryngeal squamous cell carcinoma: implications of tumor localization and tobacco exposure. Cancer Detect Prev, 28, 237-43. DOI ScienceOn |
18 | Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T (1995). Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol, 146, 1161-9. |
19 | Motokura T, Arnold A (1993). Cyclins and oncogenesis. Biochim Biophys Acta, 1155, 63-78. |
20 | Muller D, Millon R, Velten M, et al (1997). Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome. Eur J Cancer, 33, 2203-10. DOI ScienceOn |
21 | Berrino F (1999). WHO, IARC, Commision of the European Communities.Survival of Cancer Patients in Europe:The EUROCARE-2 study. IARC Sci Publ, 151, 1-572. |
22 | Betticher DC, Thatcher N, Altermatt HJ, et al (1995). Alternate splicing produces a novel cyclin D1 transcript. Oncogene, 11, 1005-11. |
23 | Betticher DC (1996). Cyclin D1, another molecule of the year? Ann Oncol, 7, 223-5. DOI ScienceOn |
24 | Boffetta P, Ye W, Adami HO, Mucci LA, et al (2001). Risk of cancers of the lung, head and neck in patients hospitalized for alcoholism in Sweden. Br J Cancer, 85, 678-82. DOI ScienceOn |
25 | Callender T, el-Naggar AK, Lee MS, et al (1994). PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer, 74, 152-8. DOI |
26 | Cann CI, Fried MP, Rothman KJ (1985). Epidemiology of squamous cell cancer of the head and neck. Otolaryngo Clin North Am, 18, 367-88. |
27 | Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H (1993). Trends in cancer incidence and mortality. IARC Sci Publ, 121, 1-806. |
28 | Gleich LL, Salamone FN (2002). Molecular genetics of head and neck cancer. Cancer Control, 9, 369-78. DOI |
29 | Dhar KK, Branigan K, Howells RE, et al (1999). Prognostic significance of cyclin D1 gene (CCND1) polymorphism in epithelial ovarian cancer. Int J Gynecol Cancer, 9, 342-7. DOI ScienceOn |
30 | Gazioglu NM, Erensoy N, Kadioglu P, Sayitoglu MA, Ersoy IH (2007). Altered cyclin D1 genotype distribution in human sporadic pituitary adenomas. Med Sci Monit, 13, 457-63. |
31 | Grieu F, Malaney S, Ward R, Joseph D, Iacopetta B (2003). Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers. Anticancer Res, 23, 4257-9. |
32 | Hall M, Peters G (1996). Genetic alterations of cyclins, cyclindependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res, 68, 67-108. DOI |
33 | Hibberts NA, Simpson DJ, Bicknell JE, et al (1999). Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors. Clin Cancer Res, 5, 2133-9. |
34 | Huang SF, Cheng SD, Chuang WY, et al (2012). Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma. World J Surg Oncol, 10, 40. DOI ScienceOn |
35 | Akervall JA, Michalides RJ, Mineta H, et al (1997). Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer, 79, 380-9. DOI |
36 | Bellacosa A, Almadori G, Cavallo S, et al (1996). Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clin Cancer Res, 2, 175-80. |
37 | Yilmaz T,Hosal AS,Gedikoglu Getal (1998).Prognostic significance of vascular and perineural invasion in cancer of the larynx. Am J Otolaryngol. 19, 83-8. DOI ScienceOn |
38 | Hunter T, Pines J (1994). Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell, 79, 573-82. DOI ScienceOn |
39 | Weinstein IB, Begemann M, Zhou P, et al (1997). Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy. Clin Cancer Res, 3, 2696-702. |
40 | Yaylim-Eraltan I, Ergen A, Gormus U, et al (2009). Breast cancer and cyclin D1 gene polymorphism in Turkish women. In Vivo, 23, 767-72. |
41 | Zhang LQ, Huang XE, Wang J, et al (2011). The cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations. Asian Pac J Cancer Prev, 12, 81-5. |
42 | Zhang J, Li Y, Wang R, et al (2003). Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population. Int J Cancer, 105, 281-4. DOI ScienceOn |
43 | Zheng Y, Shen H, Sturgis EM, et al (2001). Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis, 22, 1195-99. DOI ScienceOn |
44 | Zhuo W, Zhang L, Wang Y, Zhu B, Chen Z (2012). Cyclin D1 G870A polymorphism is a risk factor for esophageal cancer among Asians. Cancer Invest, 30, 630-6. DOI ScienceOn |
45 | Qiuling S, Yuxin Z, Suhua Z, et al (2003). Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population. Carcinogenesis, 24, 1499-503. DOI ScienceOn |
46 | Nilsson M, Chow WH, Lindblad M, Ye W (2005). No association between gastroesophageal reflux and cancers of the larynx and pharynx. Cancer Epidemiol Biomarkers Prev, 14, 1194-7. DOI ScienceOn |
47 | Nishimoto IN, Pinheiro NA, Rogatto SR, et al (2004). Cyclin D1gene polymorphism as a risk factor for squamous cell carcinoma of the upper aerodigestive system in nonalcoholics. Oral Oncol, 40, 604-10. DOI ScienceOn |
48 | Pabalan N, Bapat B, Sung L, et al (2008). Cyclin D1 Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human populations: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 17, 2773-81. DOI ScienceOn |
49 | Palmero I, Peters G (1996). Perturbation of cell cycle regulators in human cancer. Cancer Surv, 27, 351-67. |
50 | Papadimitrakopoulou V, Izzo JG, Liu DD, et al (2009). Cyclin D1 and cancer development in laryngeal premalignancy patients. Cancer Prev Res, 2, 14-21. DOI ScienceOn |
51 | Rydzanicz M, Golusinski P, Mielcarek-Kuchta D, Golusinski W, Szyfter K (2006). Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx. Eur Arch Otorhinolaryngol, 263, 43-8. DOI |
52 | Sanyal S, Festa F, Sakano S, et al (2004). Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis, 25, 729-34. |
53 | Sawa H, Ohshima TA, Ukita H, et al (1998). Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene, 16, 1701-12. DOI |
54 | Schernhammer ES, Tranah GJ, Giovannucci E et al (2006). Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma. Br J Cancer, 94, 928-34. DOI ScienceOn |
55 | Sherr CJ (1995). D-type cyclins. Trends Biochem Sci, 20, 187-90. DOI ScienceOn |
56 | Sherr CJ (1996). Cancer cell cycles. Science, 274, 1672-7. DOI ScienceOn |